Suppressing effects of 6-(2,5-dichlorophenyl)-2,4-diamino-1,3,5-triazine and related synthetic compounds on azoxymethane-induced aberrant crypt foci in rat colon

Japanese Journal of Cancer Research

Volumn 87, Issue 6, 1996, Pages 549-554

  Hirose, Yoshinobu ^a   Tanaka, Takuji ^a   Makita, Hiroki ^a   Yang, Muzheng ^a   Satoh, Kumiko ^b   Hara, Akira ^b   Maeda, Mitsuaki ^c   Toriyama, Hiroyasu Baba ^c   Mori, Hideki ^a   Tsuda, Hiroyuki ^c  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

6 (2,5 dichlorophenyl) 2,4 diamino 1,3,5 triazine; Aberrant crypt foci; Azoxymethane; Rat; Triazine derivatives

Indexed keywords

6 (2,5 DICHLOROPHENYL) 2,4 DIAMINO 1,3,5 TRIAZINE; ANTINEOPLASTIC AGENT; ANTIULCER AGENT; AZOXYMETHANE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; COLON CARCINOGENESIS; CONTROLLED STUDY; INTESTINE CRYPT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 8944224015     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00258.x     Document Type: Article

References (19)

1. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71 (1995).
2. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V. and Steele, V. E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15, 1049-1054 (1994).
3. Yamasaki, H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis, 11, 1051-1058 (1990).
4. Ueda, F., Watanabe, M., Hirata, Y., Kyoi, T. and Kimura, K. Changes in cyclic AMP content of rat gastric mucosa induced by ulcerogenic stimuli - in relation to the antiulcer activity of irsogladine maleate. Jpn. J. Pharmacol., 55, 493-499 (1991).
5. Ueda, F., Kyoi, T., Mimura, K., Kimura, K. and Yamamoto, M. Intercellular communication in cultured rabbit gastric epithelial cells. Jpn. J. Pharmacol., 57, 321-328 (1991).
6. Sato, Y., Morimoto, A., Kiue, A., Okamura, K., Hamanaka, R., Kohno, K., Kuwano, M. and Sakata, T. Irsogladine is a potent inhibitor of angiogenesis. FEBS Lett., 322, 155-158 (1993).
7. Hosokawa, T., Otani, Y., Ogawa, K. and Kajiwara, T. Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. J. Cancer Res. Clin. Oncol., 118, 565-566 (1992).
8. Hosokawa, T., Ogawa, K., Otani, Y. and Kajiwara, T. Two cases of gastric cancer remarkably reduced with a combined dosage of irsogladine maleate preparation and UFT. Oncol. Rep., 1, 93-95 (1994).
9. Kerr, J. F. R. and Harmon, B. V. Definition and incidence of apoptosis: a historical perspective. In "Apoptosis: the Molecular Basis of Cell Death," ed. L. D. Tomei and F. O. Cope, pp. 5-29 (1991). Cold Spring Harbor Laboratory Press, New York.
10. Majno, G. and Joris, I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol., 146, 3-15 (1995).
11. Kawamori, T., Tanaka, T., Kojima, T., Suzui, M., Ohnishi, M. and Mori, H. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid. Jpn. J. Cancer Res., 85, 686-691 (1994).
12. Tanaka, T., Kojima, T., Suzui, M. and Mori, H. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res., 53, 3908-3913 (1993).
13. Kawamori, T., Tanaka, T., Hara, A., Yamahara, J. and Mori, H. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res., 55, 1277-1282 (1995).
14. Koide, T., Sakai, S., Takeda, A., Doi, T., Tei, K., Hara, A. and Sawada, H. Detection of polyamines by a new enzymatic differential assay. (4) Fundamental study on a new enzymatic differential assay of blood (in Japanese). Acta Urol. Jpn., 32, 913-917 (1986).
15. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res., 45, 1-8 (1985).
16. Mori, H., Tanaka, T., Sugie, S. and Yoshimi, N. Chemopreventive effects of plant derived phenolic, organosulfur and other compounds on carcinogenesis in digestive organs. Environ. Mut. Res. Commun., 17, 127-133 (1995).
17. Toriyama-Baba, H., Maeda, M., Asamoto, M., Tokuzen, R., Uehara, N. and Tsuda, H. Inhibitory effect of triazine derivatives in rat hepatocarcinogenesis. Proc. Jpn. Cancer Assoc., 54th Annu. Meet., 54, 123 (1995).
18. Tanaka, T., Ohnishi, M., Kojima, T., Mori, H., Satoh, K. and Hara, A. Chemoprevention of N-methyl-N-nitrosourea-induced rat glandular stomach carcinogenesis by a natural product - protocatechuic acid. Cancer J., 8, 150-156 (1995).
19. Tanaka, T., Kawamori, T., Ohnishi, M., Makita, H., Mori, H., Satoh, K. and Hara, A. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis. 16, 2957-2963 (1995).